Ezra logo — Detecting cancer early using Full Body MRIs

Ezra

Detecting cancer early using Full Body MRIs

Founded 2018 United States New York, United States 81 employees Series B Total: $43.00M AI, Health Care

General Information

Company Name Ezra
Founded Year 2018
Location United States New York, United States
Employees 81
Industries AI, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Ezra. To contact Ezra, visit ezra.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ezra compare?

A PDF of Ezra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ezra soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ezra

Ezra, a health care startup founded in 2018, is driven by the mission to detect cancer early using full body MRIs. Their slogan, "Detecting cancer early using Full Body MRIs," encapsulates their core objective. Ezra offers a full body MRI scan covering up to 13 organs. The company is leveraging artificial intelligence to develop screening technologies, with the aim of improving accuracy, speed, and cost-effectiveness. In February 2024, Ezra secured a notable $21.00M Series B investment from a group of prominent backers, including FirstMark, Gaingels, LDV Capital, Allianz Life Ventures, Credo Ventures, Accomplice, Founders Future, Alumni Ventures Blockchain Fund, Esther Dyson, and Vlad Tenev. The company is headquartered in the United States. With its disruptive approach to cancer detection, Ezra presents an intriguing investment opportunity in the health tech sector.

Business keywords: cancer detection, full-body MRI, screening technology, radiology, prostate cancer, FDA-cleared software, medical imaging, health technology, early detection

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $21.00M 10
FirstMark, Gaingels +8
07 Feb 2024
Series A $18.00M -
23 Dec 2019
Seed Round $4.00M -
15 Nov 2018

Ezra Alternatives & Competitors

View All Alternatives
Ezra vs
Vara
Vara Germany

Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact...

56 employees
AI, Health Care
Ezra vs

Breast Cancer Prediction Technology

Grant
21 employees
AI, Health Care
Ezra vs

A pioneering manufacturer of cloud-based medical imaging software solutions.

Seed
16 employees
AI, Health Care

FAQ About Ezra

Detecting cancer early using Full Body MRIs
Ezra was founded in 2018.
Ezra is headquartered in New York, United States.
Ezra operates in AI and Health Care. Its work centres on cancer detection, full-body MRI, screening technology and radiology.
Ezra has approximately 81 employees.
Ezra has completed 3 funding rounds, raising a total of $43.00M. The latest funding stage is Series B.
Top alternatives and competitors to Ezra include Vara, AILIS Care, Advantis Medical Imaging, Therapixel, Smarter Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ezra and Vara are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ezra, https://bouncewatch.com/company/ezra, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes